Evidence mapPaperPMID 16609090Full record

ArticleJAMA2006

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette

11 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in JAMA, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 11 registered trials, which are not on this map. Cited by 1,037 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,037citing papers in PubMed, 4 pooled it
72.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01524705 phase4completedstarted 2012, after this paper: background citation

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR

Ran2012Enrolled102Registered outcomes4Posted comparisons3ConditionsType 2 DiabetesArmsexenatide, Insulin glargine, Metformin, Prandial insulin
Open the trial in the graph
NCT02925559 phase4completedstarted 2016, after this paper: background citation

Effect of Anti-diabetic Drugs on Glycemic Variability. A Comparison Between Gliclazide MR (Modified Release) and Dapagliflozin on Glycemic Variability Measured by Continuous Glucose Monitoring (CGM) in Patients With Uncontrolled Type 2 Diabetes

Ran2016Enrolled135Registered outcomes9Posted comparisons0ConditionsDiabetes Mellitus, Type 2Armsdapagliflozin, Gliclazide MR
Open the trial in the graph
NCT00699322 phase4unknown statusnot on this mapstarted 2008, after this paper: background citation

The Comparative Study of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on the Effect of Improving Glucose Variability and Oxidative Stress in Type 2 Diabetic Patients With Inadequate Glycemic Control on Metformin

TypeinterventionalSponsorThe Catholic University of KoreaRan2008 to 2010Enrolled36ConditionsType 2 DiabetesArmsSitagliptin, Glimepiride
NCT01083043 completednot on this map

Glycemic Variability Predicts Endothelial Dysfunction

TypeobservationalSponsorNYU Langone HealthRan2006 to 2011Enrolled28ConditionsDiabetic Vascular Complications
NCT01083433 nacompletednot on this mapstarted 2010, after this paper: background citation

Intensive Diabetes Clinic and Intermittent Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes Mellitus in Poor Glycemic Control

TypeinterventionalSponsorUniversity Hospitals Cleveland Medical CenterRan2010 to 2011Enrolled68ConditionsType 1 Diabetes MellitusArmsDiabetes related psychological counseling and education, Continuous Glucose Monitor
NCT02377388 phase3completednot on this mapstarted 2017, after this paper: background citation

DPP-4 Inhibitors in Patients With Type 2 Diabetes and Acute Myocardial Infarction:Effects on Platelet Function

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2017 to 2020Enrolled74ConditionsPlatelet Aggregation During Acute Myocardial InfarctionArmssitagliptin OR saxagliptin, placebo
NCT04692415 phase4completednot on this mapstarted 2018, after this paper: background citation

The Differences Between Insulin Glargine U300 and Insulin Degludec U100 in Impact on the Glycaemic Variability, Oxidative Stress, Arterial Stiffness and the Lipid Profiles in Insulin naïve Patients Suffering From Type Two Diabetes Mellitus

TypeinterventionalSponsorUniversity of Split, School of MedicineRan2018 to 2019Enrolled25ConditionsDiabetes Mellitus, Type 2ArmsDegludec, Glargine U300
NCT04730882 completednot on this mapstarted 2021, after this paper: background citation

Effect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy Adults

TypeobservationalSponsorUniversity of VirginiaRan2021 to 2024Enrolled36ConditionsType 1 Diabetes, Hyperglycemia, PostprandialArmsMixed Meal
NCT04920058 nacompletednot on this mapstarted 2021, after this paper: background citation

Improving Cognitive-Behavioral and Cardio-Metabolic Health Through Continuous Glucose Monitoring (CGM)

TypeinterventionalSponsorUniversity of South FloridaRan2021 to 2022Enrolled66ConditionsMetabolic SyndromeArmsContinuous Glucose Monitor, <Active Comparator?>
NCT05121844 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform: Comprehensive Weight Optimization Program and Customized Lifestyle Modifications

TypeinterventionalSponsorSignos IncRan2021 to 2027Enrolled31,187ConditionsWeight Loss, Metabolic Syndrome, Pre-diabetes, Central ObesityArmsContinuous Glucose Monitor Device
NCT07229963 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Postprandial Cardiometabolic Effects of Interrupting Sedentary Behavior With Exercise of Varying Intensity in Healthy Overweight Adults

TypeinterventionalSponsorHacettepe UniversityRan2025 to 2026Enrolled16ConditionsCardiovascular Risk Markers, Substrate Oxidation, Postprandial Metabolism, Exercise PhysiologyArmsAerobic Exercise Intervention, Sprint Exercise Intervention, Sedentary Behaviour Intervention
3 · Its place in the literature

Who cites it

1,037 citing papers in PubMed, 4 syntheses or guidelines pooled it, 2,406 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

977 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Louis MonnierDepartment of Metabolic Diseases, Lapeyronie Hospital, University of Montpellier, Montpellier, France. l-monnier@chu-montpellier.fr
Emilie Mas
Christine Ginet
Françoise Michel
Laetitia Villon
Jean-Paul Cristol
Claude Colette
Université de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextGlycemic disorders, one of the main risk factors for cardiovascular disease, are associated with activation of oxidative stress.

objectiveTo assess the respective contributions of sustained chronic hyperglycemia and of acute glucose fluctuations to oxidative stress in type 2 diabetes. DESIGN, SETTING, AND

participantsCase-control study of 21 patients with type 2 diabetes (studied 2003-2005) compared with 21 age- and sex-matched controls (studied in 2001) in Montpellier, France.

main outcome measuresOxidative stress, estimated from 24-hour urinary excretion rates of free 8-iso prostaglandin F2alpha (8-iso PGF2alpha). Assessment of glucose fluctuations was obtained from continuous glucose monitoring system data by calculating the mean amplitude of glycemic excursions (MAGE). Postprandial contribution to glycemic instability was assessed by determining the postprandial increment of glucose level above preprandial values (mean postprandial incremental area under the curve [AUCpp]). Long-term exposure to glucose was estimated from hemoglobin A1c, from fasting glucose levels, and from mean glucose concentrations over a 24-hour period.

resultsMean (SD) urinary 8-iso PGF2alpha excretion rates were higher in the 21 patients with diabetes (482 [206] pg/mg of creatinine) compared with controls (275 [85] pg/mg of creatinine). In univariate analysis, only MAGE (r = 0.86; P<.001) and AUCpp (r = 0.55; P = .009) showed significant correlations with urinary 8-iso PGF2alpha excretion rates. Relationships between 8-iso PGF2alpha excretion rates and either MAGE or AUCpp remained significant after adjustment for the other markers of diabetic control in multiple linear regression analysis (multiple R2 = 0.72 for the model including MAGE and multiple R2 = 0.41 for the model including AUCpp). Standardized regression coefficients were 0.830 (P<.001) for MAGE and 0.700 (P = .003) for AUCpp.

conclusionsGlucose fluctuations during postprandial periods and, more generally, during glucose swings exhibited a more specific triggering effect on oxidative stress than chronic sustained hyperglycemia. The present data suggest that interventional trials in type 2 diabetes should target not only hemoglobin A1c and mean glucose concentrations but also acute glucose swings.

Indexed as

Oxidative StressAgedBlood GlucoseCase-Control StudiesChronic DiseaseDiabetes Mellitus, Type 2DinoprostFemaleGlycated HemoglobinHumansHyperglycemiaLinear ModelsMaleMiddle Aged8-epi-prostaglandin F2alphaBlood GlucoseDinoprostGlycated Hemoglobin

Identifiers

PMID16609090
OpenAlexW1967265218

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 5 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.